Related Experiment Videos
[Inhibitory effects of matrix metalloproteinase inhibitor on corneal neovascularization]
T Hadeyama1, N Ebihara, Y Watanabe
1Department of Ophthalmology, Juntendo University School of Medicine, Tokyo, Japan.
Abstract:
We evaluated the inhibitory effects of matrix metalloproteinase inhibitor (MMPI) on corneal neovascularization in vivo. MMPI drops in the right eye and MMPI basic drops in the left eye were administrated six times per day after wearing a large polymethylmethacrylate-hard contact lens (PMMA-HCL) and intralamellar transplantation of a basic fibroblast growth factor (basic-FGF) containing polymer disk. We observed the status of corneal neovascularization with a slit lamp biomicroscopically after two weeks. Corneal buttons were also investigated histologically with light and electron microscopes. The findings of both investigations showed MMPI eye drops tended to inhibit the corneal neovascularization.
Insights
Matrix metalloproteinase inhibitors (MMPI) showed a tendency to inhibit corneal neovascularization. This study evaluated MMPI eye drops in a rabbit model, observing reduced blood vessel growth in the cornea.
Area of Science:
- Ophthalmology
- Vascular Biology
- Pharmacology
Context:
- Corneal neovascularization is a significant cause of vision impairment.
- Matrix metalloproteinases (MMPs) play a crucial role in angiogenesis and tissue remodeling.
- Developing effective treatments to inhibit corneal neovascularization is essential.
Purpose:
- To evaluate the inhibitory effects of matrix metalloproteinase inhibitor (MMPI) eye drops on corneal neovascularization in vivo.
- To assess the efficacy of MMPI in a rabbit model involving polymethylmethacrylate-hard contact lens (PMMA-HCL) wear and basic fibroblast growth factor (basic-FGF) delivery.
Summary:
- Matrix metalloproteinase inhibitor (MMPI) eye drops were administered to rabbits with induced corneal neovascularization.
- Corneal neovascularization was assessed biomicroscopically and histologically after two weeks of treatment.
- Both methods indicated that MMPI eye drops demonstrated an inhibitory effect on corneal neovascularization.
Impact:
- These findings suggest that MMPI eye drops may be a potential therapeutic agent for managing corneal neovascularization.
- Further research could explore optimal MMPI formulations and treatment protocols for clinical application.
- Inhibiting MMPs offers a promising strategy to preserve corneal clarity and visual function.